BR112013025112A2 - novas suspensões de nanocristais bimetálicos ouro platina, processo de manufatura eletroquímica dos mesmos e uso - Google Patents

novas suspensões de nanocristais bimetálicos ouro platina, processo de manufatura eletroquímica dos mesmos e uso Download PDF

Info

Publication number
BR112013025112A2
BR112013025112A2 BR112013025112-3A BR112013025112A BR112013025112A2 BR 112013025112 A2 BR112013025112 A2 BR 112013025112A2 BR 112013025112 A BR112013025112 A BR 112013025112A BR 112013025112 A2 BR112013025112 A2 BR 112013025112A2
Authority
BR
Brazil
Prior art keywords
platinum
aaa
water
nanocrystals
suspension
Prior art date
Application number
BR112013025112-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Adam R. Dorfman
David A. Bryce
Maxwell A. Grace
D. Kyle Pierce
Mikhail Merzliakov
Mark G. Mortenson
Original Assignee
Gr Intellectual Reserve, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gr Intellectual Reserve, Llc filed Critical Gr Intellectual Reserve, Llc
Publication of BR112013025112A2 publication Critical patent/BR112013025112A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/242Gold; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B82B3/0009Forming specific nanostructures
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C30/00Alloys containing less than 50% by weight of each constituent
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C5/00Alloys based on noble metals
    • C22C5/02Alloys based on gold
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C5/00Alloys based on noble metals
    • C22C5/04Alloys based on a platinum group metal
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
  • Powder Metallurgy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
BR112013025112-3A 2011-03-30 2012-03-30 novas suspensões de nanocristais bimetálicos ouro platina, processo de manufatura eletroquímica dos mesmos e uso BR112013025112A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161469525P 2011-03-30 2011-03-30
US61/469.525 2011-03-30
PCT/US2012/031654 WO2012135743A2 (en) 2011-03-30 2012-03-30 Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same

Publications (1)

Publication Number Publication Date
BR112013025112A2 true BR112013025112A2 (pt) 2020-09-29

Family

ID=46932416

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013025112-3A BR112013025112A2 (pt) 2011-03-30 2012-03-30 novas suspensões de nanocristais bimetálicos ouro platina, processo de manufatura eletroquímica dos mesmos e uso

Country Status (15)

Country Link
US (3) US9387225B2 (enExample)
EP (1) EP2691082B1 (enExample)
JP (1) JP6121985B2 (enExample)
KR (2) KR101955735B1 (enExample)
CN (1) CN103764123B (enExample)
BR (1) BR112013025112A2 (enExample)
CA (1) CA2829095C (enExample)
DK (1) DK2691082T3 (enExample)
ES (1) ES2564672T3 (enExample)
IL (1) IL228356A (enExample)
MX (1) MX337439B (enExample)
PH (1) PH12013501954A1 (enExample)
RU (1) RU2617055C2 (enExample)
SG (1) SG193439A1 (enExample)
WO (1) WO2012135743A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008275616B2 (en) * 2007-07-11 2014-07-10 Clene Nanomedicine, Inc. Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
EP2735389A1 (de) * 2012-11-23 2014-05-28 Universität Duisburg-Essen Verfahren zur Herstellung reiner, insbesondere kohlenstofffreier Nanopartikel
JP5891320B1 (ja) * 2015-02-12 2016-03-22 秋田県 ゼータ電位制御法を用いた処理方法
CN106680450B (zh) * 2017-03-23 2023-04-25 江西省农业科学院农业经济与信息研究所 水质监测装置及方法
US11674234B1 (en) * 2020-09-30 2023-06-13 National Technology & Engineering Solutions Of Sandia, Llc Electrodeposited platinum-gold alloy
CN112683710B (zh) * 2020-12-02 2024-04-16 大连理工大学 一种氯离子侵蚀下钢筋混凝土桥板加速腐蚀的试验装置
CN112935273A (zh) * 2021-01-26 2021-06-11 哈尔滨理工大学 一种室温制备CuPt合金纳米颗粒的方法
JP2022131579A (ja) 2021-02-26 2022-09-07 キオクシア株式会社 分析装置および分析方法
CN113500199B (zh) * 2021-06-10 2022-11-08 浙江大学 一种基于金铂双金属活性氧自生成纳米材料的制备方法及其产品和应用
CN113777034B (zh) * 2021-08-20 2024-04-19 嘉兴学院 金纳米双锥阵列基底及其制备方法和应用
CN114470201B (zh) * 2021-12-24 2024-03-19 上海市儿童医院 一种装载kcna5抗体的金铂纳米颗粒及其制备方法和应用
CN120504491B (zh) * 2025-07-21 2025-09-16 景德镇学院 一种稳定陶瓷釉料烧制发色的添加剂及其方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343047B2 (en) * 2000-02-08 2021-03-17 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US7001617B2 (en) * 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US6989157B2 (en) 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US6989156B2 (en) 2001-04-23 2006-01-24 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions
JP2002212102A (ja) * 2001-01-23 2002-07-31 Ainobekkusu Kk 電気化学的生理活性微粒子
WO2005102019A2 (en) * 2004-04-26 2005-11-03 Cap Technologies, Llc Treatment of fluids and/or sludge with electro plasma
TW200704404A (en) * 2005-03-23 2007-02-01 Shetech Co Ltd Precious metal nanocolloid solution
US20080277272A1 (en) * 2006-01-03 2008-11-13 David Kyle Pierce Methods and Apparatuses for Making Liquids More Reactive
KR100857389B1 (ko) * 2006-06-30 2008-09-11 (주)아모레퍼시픽 Ap-grr 펩티드 또는 ap-grr 펩티드를 포함하는펩티드사슬 및 이를 포함하는 약물전달담체
TW200819540A (en) * 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
AU2008275616B2 (en) 2007-07-11 2014-07-10 Clene Nanomedicine, Inc. Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
EP2200932A4 (en) * 2007-09-21 2014-09-10 Cytimmune Sciences Inc NANOTHERAPEUTIC COLLOIDAL METAL COMPOSITIONS AND METHODS
US9067263B2 (en) 2009-01-15 2015-06-30 Gr Intellectual Reserve, Llc Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom
EP2451284B8 (en) * 2009-07-08 2017-05-24 Clene Nanomedicine, Inc. Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
KR101090431B1 (ko) * 2009-08-19 2011-12-07 삼성전기주식회사 금속 씨앗을 이용한 금속 나노입자의 제조 방법 및 금속 씨앗을 함유하는 금속 나노입자

Also Published As

Publication number Publication date
CN103764123B (zh) 2018-03-13
MX2013011245A (es) 2013-10-17
SG193439A1 (en) 2013-10-30
KR20140020310A (ko) 2014-02-18
AU2012236213A1 (en) 2013-11-14
ES2564672T3 (es) 2016-03-28
CN103764123A (zh) 2014-04-30
NZ617018A (en) 2015-10-30
EP2691082B1 (en) 2016-01-13
US20230172975A1 (en) 2023-06-08
RU2013148011A (ru) 2015-05-10
KR20190027933A (ko) 2019-03-15
PH12013501954A1 (en) 2013-11-25
KR101955735B1 (ko) 2019-03-07
DK2691082T3 (en) 2016-02-29
US9387225B2 (en) 2016-07-12
JP2014518847A (ja) 2014-08-07
KR102103534B1 (ko) 2020-04-23
WO2012135743A3 (en) 2014-05-01
AU2012236213A2 (en) 2014-01-23
EP2691082A2 (en) 2014-02-05
MX337439B (es) 2016-03-03
US20140294963A1 (en) 2014-10-02
WO2012135743A2 (en) 2012-10-04
CA2829095C (en) 2019-08-27
US20160317578A1 (en) 2016-11-03
CA2829095A1 (en) 2012-10-04
EP2691082A4 (en) 2015-06-24
IL228356A (en) 2017-04-30
RU2617055C2 (ru) 2017-04-19
JP6121985B2 (ja) 2017-04-26
IL228356A0 (en) 2013-12-31

Similar Documents

Publication Publication Date Title
BR112013025112A2 (pt) novas suspensões de nanocristais bimetálicos ouro platina, processo de manufatura eletroquímica dos mesmos e uso
Feng et al. Aqueous− organic phase-transfer of highly stable gold, silver, and platinum nanoparticles and new route for fabrication of gold Nanofilms at the oil/water Interface and on solid supports
AU2022202803B2 (en) Novel gold-based nanocrystals
EP2451284B1 (en) Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
Wang et al. A galvanic replacement route to prepare strongly fluorescent and highly stable gold nanodots for cellular imaging
Pol et al. Deposition of gold nanoparticles on silica spheres: a sonochemical approach
Zidan et al. Electro-microgellation of CS/PL spheres in situ self-embedded with AgNPs as a losartan delivery system
Han et al. Combined Facile Synthesis, Purification, and Surface Functionalization Approach Yields Monodispersed Gold Nanorods for Drug Delivery Applications
Li et al. Convenient synthesis of stable silver quantum dots with enhanced photoluminescence emission by laser fragmentation
Shen et al. Fabrication of silver nanorods controlled by a segmented copolymer
AU2012236213B2 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
Wang et al. Template-free synthesis of Cu2O hollow nanospheres and their conversion into Cu hollow nanospheres
Bhattacharya et al. Chitosan-Coated Silver Nanourchins for Imatinib Mesylate Delivery: Biophysical Characterization, In-Silico Profiling, and Anti-Colon Cancer Efficacy
NZ617018B2 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
Deng Sputter deposition and formation mechanism of Pt and Pt alloy nanoparticles

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DA PRIORIDADE US 61/469,525 REIVINDICADA NO PCT/US2012/031654, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O E ART 2O DA RESOLUCAO INPI 179 DE 21/02/2017. ESTA PERDA SE DEU PELO FATO DE O DEPOSITANTE CONSTANTE DA PETICAO DE REQUERIMENTO DO PEDIDO PCT (GR INTELLECTUAL RESERVE, LLC) SER DISTINTO DAQUELES QUE DEPOSITARAM A PRIORIDADE REIVINDICADA E NAO APRESENTOU DOCUMENTO COMPROBATORIO DE CESSAO DENTRO DO PRAZO DE 60 DIAS A CONTAR DA DATA DA ENTRADA DA FASE NACIONAL, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 6O, E NO ART. 28 DA RESOLUCAO INPI-PR 77/2013.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: CLENE NANOMEDICINE, INC. (US)

B12F Other appeals [chapter 12.6 patent gazette]

Free format text: RECURSO: 870200153022 - 4/12/2020

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2641 DE 17/08/2021 POR TER SIDO INDEVIDA.

B350 Update of information on the portal [chapter 15.35 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B15Z Prolongation of time limit refused